Yann04
Senior Member (Voting Rights)
I often hear the claim that the reason ME/CFS is neglected psychologised etc. is that we don’t have a biomarker for the disease. In my opinion, it is a possibility that we have a biomarker within the next decade, even though it might only be usable in specialist laboratories.
How do you think the scene would change if this happened?
I assume, even if we have a biomarker, it wouldn’t mean we necessarily have a good understanding of the aetiology. As to how the disease is treated, is it as clear cut as many people say it is, or would we still suffer from psychosomatic medicine. An example being that even though MS is a disease with a semi-accurate biomarker (although still a diagnosis of exclusion), fatigue in MS is still often seen through the lens of the cognitive behavioural model.
How do you think the scene would change if this happened?
I assume, even if we have a biomarker, it wouldn’t mean we necessarily have a good understanding of the aetiology. As to how the disease is treated, is it as clear cut as many people say it is, or would we still suffer from psychosomatic medicine. An example being that even though MS is a disease with a semi-accurate biomarker (although still a diagnosis of exclusion), fatigue in MS is still often seen through the lens of the cognitive behavioural model.
Last edited: